Patricia Marcy, BSN, has contributed to research on schizophrenia and schizoaffective disorders, focusing on treatment approaches for early-phase schizophrenia. Her work includes studies on sustained-release medication (long-acting injectable antipsychotics) and early intervention programs for first-episode psychosis. Marcy has collaborated with notable researchers such as Christoph U. Correll and John M. Kane.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
